EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...

With a drug in advanced testing for two different indications that have spawned several blockbuster drugs, could Alumis be ...

The life sciences developer acquired the site as part of a master lease agreement with seller MIT that expires in 2099.

After 23andMe’s board of directors resigns, the president of encrypted messaging app Signal joins other security experts in ...

This approval enhances Alembic Pharma’s portfolio, which now totals 216 ANDAs from the USFDA, including 188 final and 28 ...

The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

"I've watched and been a part of Illumina growing from a startup to one of the most important and innovative companies in the ...

There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...

As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...

The European drugs regulator said on Friday it was reviewing anti hair-loss drugs, including Organon's Propecia and its ...

Wharton’s Health Care Management (HCM) MBA is another top-tier program designed to provide students with the skills needed to navigate the complex business and regulatory environment of the healthcare ...